Can High-Intensity workouts help stroke survivors regain muscle?
NCT ID NCT07456956
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether high-intensity interval training (HIIT) is better than moderate continuous exercise for treating muscle loss (sarcopenia) in people who have had an ischemic stroke. Researchers will measure changes in thigh muscle thickness, grip strength, walking ability, and quality of life in 32 participants over 6 weeks. The goal is to find the best exercise approach to improve recovery and daily function after a stroke.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MCIT) exercise programs
- What this could lead to
- If successful, this study could show that HIIT is a more effective exercise approach than moderate training for rebuilding muscle and improving mobility after a stroke.
- What could go wrong
- This is a small, early-stage trial with only 32 participants, so results may not apply to all stroke survivors. Exercise intensity may be hard for some to tolerate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 32 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * First-ever stroke. * Age 18 years or older. * Diagnosis of ischemic stroke. * Stroke duration between 1-6 months (subacute phase). * Modified Rankin Scale score \< 3. * Mini-Mental State Examination (MMSE) score ≥ 24. * Brunnstrom lower extremity motor stage between Stage III-V. * Lower extremity functional capacity sufficient to allow exercise participation (able to ambulate at least with an assistive device). * Lower extremity spasticity ≤ 2 according to the Modified Ashworth Scale. * Independent sitting balance (able to sit unsupported for at least 30 seconds). * Presence of sufficient voluntary active movement in the lower extremity to permit exercise application. * Ability to communicate. * Willingness to participate in the study and provision of written informed consent. Exclusion Criteria: * Presence of hemispatial neglect. * History of recurrent stroke. * Presence of a psychiatric disorder. * Presence of orthopedic, neurological, or cardiopulmonary conditions that would contraindicate the planned exercise protocols.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sarcopenia are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Fenerbahçe University
RECRUITINGIstanbul, Ataşehir, 34758, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A multi-center, randomized, double-blind, placebo-controlled, phase 1/2 clinical trial to evaluate the efficacy and safety of EN001 in patients with sarcopenia
- A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase ⅱb/ⅲ clinical study to evaluate the efficacy and safety of XY03-EA tablets in the treatment of acute ischemic stroke
- Skeletal muscle myosin binding protein c in fatigue and aging
- Can exercise counteract Cancer's muscle wasting?
- Hidden muscle loss in Sjögren's syndrome: a new study looks for answers
- Ancient herbal formula put to the test against Age-Related muscle loss